Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stacey J Adam

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Plos Genetics|June 2, 2012
Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesisPhuoc T Tran, Emelyn H Shroff, Timothy F Burns, et al.
JCO Precision Oncology|September 7, 2023
Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP)Riha Vaidya, Joseph M Unger, Lu Qian, et al.
Journal of Clinical and Translational Science|October 31, 2024
ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemicMaryam Keshtkar-Jahromi, Kevin J Anstrom, Christina Barkauskas, et al.
Journal of Clinical and Translational Science|November 14, 2024
ACTIV trials: cross-trial lessons learned for master protocol implementationMaryam Keshtkar-Jahromi, Stacey J Adam, Indira Brar, et al.
The New England Journal of Medicine|September 21, 2023
Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19David R Boulware, Christopher J Lindsell, Thomas G Stewart, et al.
The Journal of Infectious Diseases|June 3, 2025
The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or DeathAllyson Mateja, Eric Chu, Thomas A Murray, et al.
The Journal of Infectious Diseases|August 20, 2025
Evaluating viral load sampling schemes and swabbing methods for optimal surrogacyAllyson Mateja, Eric Chu, Thomas A Murray, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2023
Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think TankShanti Narayanasamy, Lesley H Curtis, Adrian F Hernandez, et al.
Medrxiv : the Preprint Server for Health Sciences|October 27, 2022
Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical TrialMatthew W McCarthy, Susanna Naggie, David R Boulware, et al.
JAMA|January 12, 2023
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical TrialMatthew W McCarthy, Susanna Naggie, David R Boulware, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Plos Genetics|June 2, 2012
Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesisPhuoc T Tran, Emelyn H Shroff, Timothy F Burns, et al.
JCO Precision Oncology|September 7, 2023
Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP)Riha Vaidya, Joseph M Unger, Lu Qian, et al.
Journal of Clinical and Translational Science|October 31, 2024
ACTIV trials: Lessons learned in trial design in the setting of an emergent pandemicMaryam Keshtkar-Jahromi, Kevin J Anstrom, Christina Barkauskas, et al.
Journal of Clinical and Translational Science|November 14, 2024
ACTIV trials: cross-trial lessons learned for master protocol implementationMaryam Keshtkar-Jahromi, Stacey J Adam, Indira Brar, et al.
The New England Journal of Medicine|September 21, 2023
Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19David R Boulware, Christopher J Lindsell, Thomas G Stewart, et al.
The Journal of Infectious Diseases|June 3, 2025
The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or DeathAllyson Mateja, Eric Chu, Thomas A Murray, et al.
The Journal of Infectious Diseases|August 20, 2025
Evaluating viral load sampling schemes and swabbing methods for optimal surrogacyAllyson Mateja, Eric Chu, Thomas A Murray, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 12, 2023
Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think TankShanti Narayanasamy, Lesley H Curtis, Adrian F Hernandez, et al.
Medrxiv : the Preprint Server for Health Sciences|October 27, 2022
Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical TrialMatthew W McCarthy, Susanna Naggie, David R Boulware, et al.
JAMA|January 12, 2023
Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical TrialMatthew W McCarthy, Susanna Naggie, David R Boulware, et al.
Pageof 5